Skip to main content

Table 1 The demographic data of included cases

From: Vaccine-associated complications: a comparative multicenter evaluation among dental practitioners and dental students—which candidate vaccine is more safe in SARS COV II, Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBP-CorV(Sinopharm)?

 

Number

Percent

Gender (female)

681

60.2%

Occupation

Dental student

104

9.2%

Postgraduate dental student

178

15.7%

General dentist

831

73.4%

Professional dentist

19

1.7%

History of coronavirus infections

269

23.8%

Infected once

245

21.6%

Infected more than once

24

2.2%

History of previous viral infections

Influenza

318

28.1%

MERS,

1

0.1%

EBV (mononucleosis)

17

1.5%

None

796

70.3%

Type of administered vaccine

ChAdOx1 nCoV-19

578

51.1%

Gam-COVID-Vac

426

37.6%

BBV152

25

2.2%

BBIBP-CorV

102

9.0%

Onset of vaccine side effects:

0–12 h

499

44.1%

12–24 h

328

29.0%

1–2 d

96

8.5%

3–4 d

19

1.7%

5–7 d

9

0.8%

1–2 w

12

1.1%

3–4 w

3

0.3%

No side effect

166

14.7%

How long after vaccine that you have side effects (duration of side effects)

Few hours

191

16.9%

1 d

498

44.0%

1–3 d

358

31.6%

3–7 d

48

4.2%

7–14 d

10

0.9%

>14 d

4

0.4%

None

23

2.0%

  1. Abbreviations: h hour, d day, w week